ClinicalTrials.Veeva

Menu

Mindfulness Breath Awareness Meditation and Preeclampsia

A

Aysegul Kilicli

Status

Enrolling

Conditions

Mindfulness Breath Awareness Meditation
Preeclampsia

Treatments

Behavioral: Mindfulness breath awareness meditation

Study type

Interventional

Funder types

Other

Identifiers

NCT06065709
MEDITATION AND PREECLAMPSİA

Details and patient eligibility

About

The effect of mindfulness breath awareness meditation on health profile, vital signs, and fetal heart rate in pregnant women with preeclampsia

Full description

The aim of this study is to determine the effect of mindfulness breath awareness meditation (MBAM) on health profile, vital signs, and fetal heart rate in pregnant women with preeclampsia.

Sample size:

  • There will be two groups in the study.
  • Experiment group is breath awareness meditation group.
  • The sample size of the study is 66 women.
  • The sample size will be divided into two and 33 women will be randomly assigned to each group.

Application time:

  • The application will be started after the pregnant women diagnosed with pre-eclampsia is admitted to the Perinatology service.
  • It will be applied total nine times in once every eight hours during the 72 hours that the pregnant women diagnosed with 20 minutes.
  • Only mindfulness breath awareness meditation (MBAM) will not be applied to the control group. Care and follow-up will be performed in parallel with the individuals in the experimental group.

Data Collection Tools:

  • Descriptive Information Form
  • Nottingham Health Profile Scale

Measurement time:

  • Pregnant women will fill in the Introductory Information Form before the first application.
  • Each session of mindfulness breath awareness meditation practice will 20 minutes.
  • Pregnant women will fill the Nottingham Health Profile Scale before the first application. It will then be refilled at the same time every 24 hours for 72 hours. The Nottingham Health Profile will be completed a total of four times.
  • Vital signs (systolic and diastolic blood pressure, body temperature, pulse, respiration, oxygen saturation) will be measured immediately before the first application. They will then be refilled at the same time every 24 hours for 72 hours. Vital signs will be completed a total of four times.
  • Fetal heart rate and fetal movement count will be measured immediately before the first application. They will then be refilled at the same time every 24 hours for 72 hours. Fetal heart rate and fetal movement count will be assessed by Non-stress Testing (NST). The pregnant woman will undergo NST for 20 minutes.

Enrollment

66 estimated patients

Sex

Female

Ages

19 to 49 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • pregnant women who is admitted to the Perinatology Service of the hospital with the diagnosis of preeclampsia,
  • who is 19 to 49 years old,
  • who is 20 and over weeks of gestation,
  • who followes by at least three days of hospitalization in the ward.

Exclusion criteria

  • Pregnant women who do not meet the inclusion criteria and who voluntarily withdraw at any stage after inclusion will be excluded from the study.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

66 participants in 2 patient groups

Mindfulness breath awareness meditation group
Experimental group
Description:
Mindfulness breath awareness meditation will be performed nine times in total, once every eight hours within 72 hours, to the pregnant woman who is hospitalised in the perinatology service of the hospital with the diagnosis of preeclampsia. Each session will last 30 minutes. A 4-stage mindfulness breath awareness meditation includes the following stages: Stage 1 - Body Harmony. Stage 2 - Counting as you Exhale Stage 3 - Counting while Breathing Stage 4 - Sit Still and Witness.
Treatment:
Behavioral: Mindfulness breath awareness meditation
control group
No Intervention group
Description:
only mindfulness breath awareness meditation will not be applied to the control group.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems